The Hsp60 as a potential target of antiviral compound BPR3P0128 and its role in influenza virus replication
碩士 === 長庚大學 === 生物醫學研究所 === 99 === Influenza virus remains one of major pathogens that cause large morbidity and mortality in the world every year. Although there are two efficient neuraminidase inhibitors, oseltamivir and zanamivir, available for clinical treatment, the emergence of resistant influ...
Main Authors: | Chun Chi Chang, 張峻齊 |
---|---|
Other Authors: | J. T. Horng |
Format: | Others |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/95380843468230572038 |
Similar Items
-
BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71
by: Arul Balaji Velu, et al.
Published: (2016) -
Inhibiting influenza virus replication using novel and established antiviral compounds
by: Brookes, Daniel William
Published: (2011) -
Stub Record for Image YMCA_0128.tif
Published: () -
Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma
by: Carolina Caro-Vegas, et al.
Published: (2019-02-01) -
Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity
by: Yeh Jiann-Yih, et al.
Published: (2010-02-01)